PTEN: from pathology to biology

被引:280
作者
Sulis, ML
Parsons, R [1 ]
机构
[1] Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10027 USA
[2] Columbia Univ, Div Pediat Oncol, Childrens Hosp, Herbert Irving Canc Ctr,Coll Phys & Surg, New York, NY USA
[3] Columbia Univ, Coll Phys & Surg, Dept Pathol, Herbert Irving Canc Ctr, New York, NY USA
[4] Columbia Univ, Coll Phys & Surg, Dept Med, Herbert Irving Canc Ctr, New York, NY USA
关键词
D O I
10.1016/S0962-8924(03)00175-2
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The PTEN tumour suppressor gene is mutated frequently in many malignancies and its importance in the development of cancer is probably underestimated. As the primary phosphatase of phosphatidlylinositol (3,4,5)-trisphosphate, PTEN has a central role in reigning in the phosphoinositide 3-kinase (PI 3-kinase) network to control cellular homeostasis. Cells that lack PTEN are unable to regulate the Ptdlns 3-kinase programme, which stimulates a variety of cellular phenotypes that favour oncogenesis. As well as the well-known role as tumour suppressor, recent studies show that PTEN is involved in the regulation of several basic cellular functions, such as cell migration, cell size, contractility of cardiac myocytes and chemotaxis. Here, we review the roles of PTEN in normal cellular functions and disease development.
引用
收藏
页码:478 / 483
页数:6
相关论文
共 70 条
[1]   Phosphorylation of HDM2 by Akt [J].
Ashcroft, M ;
Ludwig, RL ;
Woods, DB ;
Copeland, TD ;
Weber, HO ;
MacRae, EJ ;
Vousden, KH .
ONCOGENE, 2002, 21 (13) :1955-1962
[2]   Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease [J].
Backman, SA ;
Stambolic, V ;
Suzuki, A ;
Haight, J ;
Elia, A ;
Pretorius, J ;
Tsao, MS ;
Shannon, P ;
Bolon, B ;
Ivy, GO ;
Mak, TW .
NATURE GENETICS, 2001, 29 (04) :396-403
[3]   Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor [J].
Brunet, A ;
Bonni, A ;
Zigmond, MJ ;
Lin, MZ ;
Juo, P ;
Hu, LS ;
Anderson, MJ ;
Arden, KC ;
Blenis, J ;
Greenberg, ME .
CELL, 1999, 96 (06) :857-868
[4]   New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase AKT pathway [J].
Cantley, LC ;
Neel, BG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4240-4245
[5]   Regulation of cell death protease caspase-9 by phosphorylation [J].
Cardone, MH ;
Roy, N ;
Stennicke, HR ;
Salvesen, GS ;
Franke, TF ;
Stanbridge, E ;
Frisch, S ;
Reed, JC .
SCIENCE, 1998, 282 (5392) :1318-1321
[6]   A testis-specific gene, TPTE, encodes a putative transmembrane tyrosine phosphatase and maps to the pericentromeric region of human chromosomes 21 and 13, and to chromosomes 15, 22, and Y [J].
Chen, HM ;
Rossier, C ;
Morris, MA ;
Scott, HS ;
Gos, A ;
Bairoch, A ;
Antonarakis, SE .
HUMAN GENETICS, 1999, 105 (05) :399-409
[7]   Drosophila phosphoinositide-dependent kinase-1 regulates apoptosis and growth via the phosphoinositide 3-kinase-dependent signaling pathway [J].
Cho, KS ;
Lee, JH ;
Kim, S ;
Kim, D ;
Koh, H ;
Lee, J ;
Kim, C ;
Kim, J ;
Chung, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (11) :6144-6149
[8]   Control of cell polarity and chemotaxis by Akt/PKB and PI3 kinase through the regulation of PAKa [J].
Chung, CY ;
Potikyan, G ;
Firtel, RA .
MOLECULAR CELL, 2001, 7 (05) :937-947
[9]   Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways [J].
Crackower, MA ;
Oudit, GY ;
Kozieradzki, I ;
Sarao, R ;
Sun, H ;
Sasaki, T ;
Hirsch, E ;
Suzuki, A ;
Shioi, T ;
Irie-Sasaki, J ;
Sah, R ;
Cheng, HYM ;
Rybin, VO ;
Lembo, G ;
Fratta, L ;
Oliveira-dos-Santos, AJ ;
Benovic, JL ;
Kahn, CR ;
Izumo, S ;
Steinberg, SF ;
Wymann, MP ;
Backx, PH ;
Penninger, JM .
CELL, 2002, 110 (06) :737-749
[10]   INHIBITION OF GLYCOGEN-SYNTHASE KINASE-3 BY INSULIN-MEDIATED BY PROTEIN-KINASE-B [J].
CROSS, DAE ;
ALESSI, DR ;
COHEN, P ;
ANDJELKOVICH, M ;
HEMMINGS, BA .
NATURE, 1995, 378 (6559) :785-789